• Transactions of the Korean Society of Automotive Engineers
• /
• v.22 no.3
• /
• pp.42-49
• /
• 2014

The gasoline direct injection (GDI) system is considerably spreading in automotive market due to its advantages. Nevertheless, since GDI system emit higher particle matter (PM) due to its combustion characteristics, it is difficult to meet strengthened emission regulation in near future. For this reason, a combined GDI with MPI system, so-called, dual injection (DUI) system is being investigated as a supplemental measure for the GDI system. This paper focused on power and fuel consumption effect by injection mode strategy of DUI system in part load and idle engine operating condition. In this study, port fuel injectors are installed on 2.4 liters GDI production engine in order to realize DUI system. And, at each injection mode, DOE (design of experiment) method is used to optimize engine control parameters such as dual injection ratio, start of injection timing, end of injection timing, CAM position and so on. As a consequence, DUI mode shows slightly better or equivalent fuel efficiency compared to conventional GDI engine on 9 points fuel economy mode as well as MPI mode shows less fuel consumption than GDI mode during idle operation. Furthermore, DUI system shows improvement potential of maximum 2.0% fuel consumption and 1.1% performance compared to GDI system in WOT operating condition.

• Journal of Radiation Protection and Research
• /
• v.39 no.4
• /
• pp.159-167
• /
• 2014

In Korea, July 2012, the law as called 'Act on Safety Control of Radioactive Rays Around Living Environment' was implemented to control the consumer product containing Naturally Occurring Radioactive Material (NORM), but, there are no appropriate database and effective dose calculation system. The aim of this study was to develop evaluation technique of the exposure dose with the use of the consumer products containing NORM and to understand the characteristics of the exposed dose according to the radiation type and energy. For the evaluate of exposure dose, the ICRP reference phantom was simulated by the MCNPX code based on Monte Carlo method, and the minimum, medium, maximum energy of alphas, betas, gammas from the representative NORM of Uranium decay series were used as the source term in the simulation. The annual effective doses were calculated by the exposure scenario of the consumer product usage time and position. Short range of the alpha and beta rays are mostly delivered the dose to the skin. On the other hand, the gamma rays mostly delivered the similar dose to all of the organs. The results of the annual effective dose with $1Bq{\cdot}g^{-1}$ radioactive stone-bed and 10% radioactive concentration were employed with the usage time of 7 hours 50 minute per day, the maximum annual effective dose of alphas, betas, gammas were calculated 0.0222, 0.0836, $0.0101mSv{\cdot}y^{-1}$, respectively.

• Radiation Oncology Journal
• /
• v.33 no.4
• /
• pp.337-343
• /
• 2015

Purpose: The purpose of this report is to describe the proton therapy system at Samsung Medical Center (SMC-PTS) including the proton beam generator, irradiation system, patient positioning system, patient position verification system, respiratory gating system, and operating and safety control system, and review the current status of the SMC-PTS. Materials and Methods: The SMC-PTS has a cyclotron (230 MeV) and two treatment rooms: one treatment room is equipped with a multi-purpose nozzle and the other treatment room is equipped with a dedicated pencil beam scanning nozzle. The proton beam generator including the cyclotron and the energy selection system can lower the energy of protons down to 70 MeV from the maximum 230 MeV. Results: The multi-purpose nozzle can deliver both wobbling proton beam and active scanning proton beam, and a multi-leaf collimator has been installed in the downstream of the nozzle. The dedicated scanning nozzle can deliver active scanning proton beam with a helium gas filled pipe minimizing unnecessary interactions with the air in the beam path. The equipment was provided by Sumitomo Heavy Industries Ltd., RayStation from RaySearch Laboratories AB is the selected treatment planning system, and data management will be handled by the MOSAIQ system from Elekta AB. Conclusion: The SMC-PTS located in Seoul, Korea, is scheduled to begin treating cancer patients in 2015.